Do amlodipine and amiodarone lower heart rate and blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Amlodipine and Amiodarone Lower Heart Rate and Blood Pressure?

Yes, both amlodipine and amiodarone lower blood pressure, but their effects on heart rate differ substantially: amlodipine does NOT significantly lower heart rate, while amiodarone DOES lower heart rate through its effects on AV nodal conduction.

Amlodipine Effects

Blood Pressure

Amlodipine is a dihydropyridine calcium channel blocker that effectively lowers blood pressure through peripheral arterial vasodilation 1. The FDA label confirms it produces vasodilation resulting in reduction of both supine and standing blood pressures, with antihypertensive effectiveness maintained for at least 24 hours with once-daily dosing 1. Clinical trials demonstrate dose-related blood pressure reduction, with 2.5 mg being the minimum effective dose 2.

Heart Rate

Amlodipine does NOT significantly affect heart rate 1. The FDA label explicitly states that "chronic oral administration of amlodipine in clinical trials did not lead to clinically significant changes in heart rate" and that "decreases in blood pressure are not accompanied by a significant change in heart rate or plasma catecholamine levels with chronic dosing" 1. This is confirmed by research showing no change in resting heart rate despite therapeutic plasma concentrations 3. While acute intravenous administration may transiently increase heart rate, chronic oral use maintains stable heart rate 1.

Amiodarone Effects

Heart Rate

Amiodarone significantly lowers heart rate through multiple mechanisms 4. Guidelines describe amiodarone as having "both sympatholytic and calcium antagonistic properties, depresses AV conduction, and is effective for controlling the ventricular rate" 4.

Recent research demonstrates:

  • Pediatric patients showed significant heart rate decrease, most pronounced until cumulative dose of 30,000 mcg/kg 5
  • Adult cardiac surgical patients experienced mean heart rate reduction of 11.5 beats per minute 6
  • Critically ill patients with atrial tachyarrhythmias had heart rate decreased by 37 ± 8 beats/min 7

Blood Pressure

Amiodarone's effect on blood pressure is complex and context-dependent:

Acute IV administration causes transient hypotension 6, 8. In cardiac surgical patients, IV amiodarone decreased mean arterial pressure by 14 mm Hg at 6 minutes, though this was transient and resolved within 15 minutes 6. The mechanism is primarily selective arterial vasodilation rather than myocardial depression, as left ventricular performance is maintained 6.

However, in patients with rapid atrial tachyarrhythmias, amiodarone paradoxically INCREASES blood pressure by controlling heart rate 7. In critically ill patients with atrial fibrillation/flutter, amiodarone infusion was associated with an INCREASE in systolic blood pressure of 24 ± 6 mm Hg while simultaneously decreasing heart rate 7.

Clinical Context and Caveats

Amiodarone for Rate Control

Guidelines position amiodarone as a second-line agent for rate control due to toxicity concerns 4, 9. The 2011 ACC/AHA/ESC guidelines state: "important adverse effects make this agent a second-line therapy for rate control" and "the potential benefit must be carefully weighed against the considerable potential toxicity of this drug" 4.

Amiodarone is recommended for rate control when:

  • Beta blockers, diltiazem, or verapamil are contraindicated or ineffective 10
  • Patients have systolic heart failure 10
  • Patients are critically ill with hemodynamic instability 4

Important Drug Interaction

When used together, monitor for additive blood pressure lowering effects 11. The 2025 AHA/ACC hypertension guidelines note that amiodarone is a CYP2D6 inhibitor that can increase concentrations of beta blockers (bisoprolol, carvedilol, metoprolol), potentially enhancing hypotension and bradycardia 11.

Toxicity Considerations

Long-term amiodarone carries significant risks including pulmonary fibrosis, hepatic injury, thyroid dysfunction, and proarrhythmia 4, 12. Therefore, it should not be used for chronic rate control when other options are available 9.

References

Research

Effect of amlodipine on cardiopulmonary performance in volunteers.

Clinical and experimental pharmacology & physiology, 2001

Guideline

amiodarone: guidelines for use and monitoring.

American family physician, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.